Tamoxifen: A protein kinase c inhibitor to treat mania a systematic review and meta-analysis of randomized, placebo-controlled trials

Journal of Clinical Psychopharmacology

Volumn 36, Issue 3, 2016, Pages 272-275

  Talaei, Ali ^a   Pourgholami, Meysam ^a   Khatibi Moghadam, Hoda ^a   Faridhosseini, Farhad ^a   Farhoudi, Fatemeh ^a   Askari Noghani, Arash ^a   Sadeghi, Ramin ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bipolar disorder; Mania; Meta analysis; Protein kinase cinhibitor; Tamoxifen

Indexed keywords

PROTEIN KINASE C INHIBITOR; TAMOXIFEN; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR;

CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; MANIA; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; BIPOLAR DISORDER; PROCEDURES;

BIPOLAR DISORDER; HUMANS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAMOXIFEN;

EID: 84964446429     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000492     Document Type: Review

References (17)

1. Faridhosseini F, Sadeghi R, Farid L, et al. Celecoxib: A new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials. Hum Psychopharmacol. 2014;29:216-223.
2. Armani F, Andersen ML, Andreatini R, et al. Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model. CNS Neurosci Ther. 2012;18:119-125.
3. Hahn CG, Friedman E. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord. 1999;1:81-86.
4. Dubovsky SL. Calcium antagonists in manic-depressive illness. Neuropsychobiology. 1993;27:184-192.
5. Willems PH, Pahle J, Stalpers XL, et al. PKC-mediated inhibitory feedback of the cholecystokinin 1 receptor controls the shape of oscillatory ca signals. FEBS J. 2015;282:2187-2201.
6. Zarate A, Manji HK. Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs. 2009;23: 569-582.
7. Kulkarni J, Berk M, Wang W, et al. A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania. Psychoneuroendocrinology. 2014;43:52-61.
8. Kulkarni J, Garland KA, Scaffidi A, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology. 2006;31:543-547.
9. Amrollahi Z, Rezaei F, Salehi B, et al. Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord. 2011;129:327-331.
10. Yildiz A, Guleryuz S, Ankerst DP, et al. Protein kinase C inhibition in the treatment of mania: A double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry. 2008;65:255-263.
11. Zarate CA, Singh JB, Carlson PJ, et al. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: A pilot study. Bipolar Disord. 2007;9:561-570.
12. Bowden CL. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J Clin Psychiatry. 1998;59:13-19.
13. Vieta E, Sanchez-Moreno J. Acute and long-term treatment of mania. Dialogues Clin Neurosci. 2008;10:165-179.
14. Cathcart CK, Jones SE, Pumroy CS, et al. Clinical recognition and management of depression in node-negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 1993;27:277-281.
15. Legha SS. Tamoxifen in the treatment of breast cancer. Ann Intern Med. 1988;109:219-228.
16. Fisher B, Costantino JP, Redmond CK, et al. Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J NatlCancer Inst. 1994;86:527.
17. Kedar RP, Bourne TH, Powles TJ, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet. 1994;343:1318-1321.